Huizinga Robert Bindert's Form 4 filing
Aurinia Pharmaceuticals Inc. (AUPH) · filed Sep 22, 2021
- Accession no.
- 0001628280-21-019051
- Filed
- Sep 22, 2021
- Trade date
- Sep 21, 2021
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $779.5K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Huizinga Robert BindertCIK 0001837648 | Officer (EVP of Research) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 21, 2021 | Common Stock | MOption exerciseAcquired | +16,000 | $2.63 | +$42,080 | 122,092 | Direct | |
| Sep 21, 2021 | Common Stock | MOption exerciseAcquired | +11,136 | $3.20 | +$35,635.2 | 133,228 | Direct | |
| Sep 21, 2021 | Common Stock | SSaleDisposed | −27,136 | $24.05 | −$652,620.8 | 106,092 | Direct | |
| Sep 21, 2021 | Common Stock | SSaleDisposed | −5,364 | $23.66 | −$126,912.24 | 100,728 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 21, 2021 | Common Stock | MOption exerciseDisposed | −16,000 | $0.00 | $0 | 0 | Direct | |
| Sep 21, 2021 | Common Stock | MOption exerciseDisposed | −11,136 | $0.00 | $0 | 98,864 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.